secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acumen Pharmaceuticals, Inc. (ABOS)
CIK:        0001576885
Form:       8-K
Filed at:   2022-09-12T23:59:59+00:00
Accession:  0001193125-22-242461
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acumen posts updated corporate presentation on website; no new material data disclosed
--------------------------------------------------------------------------------

- Company posted updated corporate presentation dated September 2022 to its investor website on September 12, 2022.
- Presentation may be used in communications or conferences; filing under Regulation FD.
- No specific financial, clinical, or operational updates provided in the 8-K filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1576885/000119312522242461/0001193125-22-242461-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1576885/000119312522242461/d267556d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-242461

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer